Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 51.24M | 48.48M | 47.27M | 44.44M | 45.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.24M | 48.48M | 47.27M | 44.44M | 45.30M |
| Cost of Revenue | 12.74M | 11.98M | 12.47M | 12.05M | 13.00M |
| Gross Profit | 38.51M | 36.50M | 34.80M | 32.39M | 32.29M |
| SG&A Expenses | 43.82M | 40.78M | 39.11M | 36.01M | 35.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.44M | 63.42M | 61.64M | 58.11M | 59.61M |
| Operating Income | -17.20M | -14.93M | -14.37M | -13.67M | -14.32M |
| Income Before Tax | -16.60M | -14.14M | -12.97M | -12.79M | -13.48M |
| Income Tax Expenses | -- | -- | 43.00K | -- | -- |
| Earnings from Continuing Operations | -16.60M | -14.14M | -13.01M | -12.79M | -13.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.60M | -14.14M | -13.01M | -12.79M | -13.48M |
| EBIT | -17.20M | -14.93M | -14.37M | -13.67M | -14.32M |
| EBITDA | -16.53M | -14.29M | -13.72M | -13.02M | -13.63M |
| EPS Basic | -0.42 | -0.36 | -0.33 | -0.33 | -0.35 |
| Normalized Basic EPS | -0.26 | -0.23 | -0.21 | -0.21 | -0.22 |
| EPS Diluted | -0.42 | -0.36 | -0.33 | -0.33 | -0.35 |
| Normalized Diluted EPS | -0.26 | -0.23 | -0.21 | -0.21 | -0.22 |
| Average Basic Shares Outstanding | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M |
| Average Diluted Shares Outstanding | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
